Fig 5 - by Lauren K. Sara (11307376)

Fig. 5 by James Humble (791779)

Fig 5 - by Rong Yang (107028)

Case Ⅴ. by Jie Li (15030)

Fig 5 - by Joon Young Park (15256702)

Fig 5 - by Seishiro Hirano (65790)

“…<p>Changes in the percentage of cells with agglomerated PML–NBs (A), and recovery of PML in the RIPA–soluble fraction (Sol) from a 24 h–exposure to As³⁺ in CHOGFPPML cells (B). …”

Fig 5 - by Serena Y. Zhao (15188339)

Fig 5 - by Lilian Konicar (9954320)

“…Changes in resting state EEG before and after SCP neurofeedback at midline regions (5a: left) and parietotemporal regions (5b: right) during the eyes-closed condition. …”

Presentation_1_Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells.pptx by Ágata Lopes-Ribeiro (14131932)

“…Furthermore, a decrease in combined prediction score was observed for HLA-A*02-restricted epitopes when the original strain was compared to the VOCs, indicating that the mutations on the VOCs are promoting escape from HLA-A2-mediated antigen presentation, which characterizes a immune evasion process. …”

S5 Table - by Marisa R. Pinson (11659514)

Fig 5 - by Drew F. K. Williamson (12133411)

S5 Data - by Renjie Wang (1986553)

“…PI_ABS, W_K, V_J, and ΔI/I₀ decreased over time, while Rubisco enzyme activity decreased, while proline (Pro) levels increased. …”

MC^α2 bursts synchronize type A PC firing in slow frequencies. by Markus M. Hilscher (473981)

Fig 5 - by Ali Rezaie (738507)

Periodicity of IgE. by Hiromi Yamaguchi (2396248)

Temporal negative correlation between total fertility rate and KD incidence. by Hiromi Yamaguchi (2396248)

Berberine decreases 4-AP-induced phosphorylation of ERK1/2 and synapsin I, and this effect is prevented by PD98059. by Tzu-Yu Lin (423761)

Predicted accuracy of classification functions on the basis of the characteristics of the expression values obtained for 5,207 Transcript clusters ‘present’ in the MCTs. by Kelly Bowlt Blacklock (6102878)

Indicators of community mobility in Fukuoka prefecture. by Hiromi Yamaguchi (2396248)

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant by Yingxia Wen (2455015)

“…Also, bivalent proteins (A244.AE and 6240.B) formulated with MF59 elicited distinct V2-specific Abs to the epitope previously shown to correlate with decreased risk of HIV-1 infection in the RV144 trial. …”